Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Tofacitinib is an effective and safe treatment for alopecia areata.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Three compounds from Dadap leaves may help treat hair loss.

The document concludes that scalp conditions have various causes and can present in many different ways.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.